Krystal Biotech, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report3 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Krystal Biotech, Inc.
330.32
−8.37%
vs ±10.1% implied · ×0.83
shaded = implied · ▲▼ = realized
Fund move
Fund move
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $1.6B | 14.37% | +1.01% | |
| 2 | BlackRockBlackRockindex-like | $1.6B | 13.60% | +6.12% | |
| 3 | venBio Select AdvisorvenBio Select Advisor | $1.1B | 9.40% | 0.00% | |
| 4 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $585.3M | 5.12% | +8.11% | |
| 5 | State StreetState Streetindex-like | $502.2M | 4.40% | +2.79% | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $461.1M | 4.04% | +6.46% | |
| 7 | Soleus Capital ManagementSoleus | $349.1M | 3.06% | −18.54% | |
| 8 | Capital World InvestorsCapital World Investors | $289.1M | 2.53% | −5.68% | |
| 9 | Vestor CapitalVestor Capital | $260.5M | 2.28% | +350357.00% | |
| 10 | Geode Capital ManagementGeodeindex-like | $259.8M | 2.27% | +8.54% | |
| 11 | T. Rowe Price AssociatesT. Rowe Price | $255.5M | 2.24% | +41.71% | |
| 12 | Hood River Capital ManagementHood River | $246.6M | 2.16% | +7.07% | |
| 13 | Redmile GroupRedmile | $234.9M | 2.06% | −6.16% | |
| 14 | William Blair Investment ManagementWilliam Blair | $211.9M | 1.85% | +40.03% | |
| 15 | Frazier Life Sciences ManagementFrazier Life Sciences | $178.9M | 1.57% | 0.00% | |
| 16 | Dimensional Fund AdvisorsDimensional | $176.9M | 1.55% | +1.50% | |
| 17 | First Trust AdvisorsFirst Trust | $120.8M | 1.06% | −7.31% | |
| 18 | InvescoInvesco | $120.7M | 1.06% | new | |
| 19 | Goldman Sachs GroupGoldman Sachs | $111.1M | 0.97% | +39.03% | |
| 20 | Northern TrustNorthern Trustindex-like | $105.5M | 0.92% | +12.41% | |
| 21 | Franklin ResourcesFranklin Resources | $97.3M | 0.85% | +46.11% | |
| 22 | Norges BankNorges Bankindex-like | $96.3M | 0.84% | — | |
| 23 | Jupiter TopcoJupiter Topco | $95.4M | 0.83% | — | |
| 24 | Bank of AmericaBank of America | $95.3M | 0.83% | −1.62% | |
| 25 | Charles Schwab Investment ManagementCharles Schwabindex-like | $94.7M | 0.83% | +5.31% |
423 managers report $11.4B of Krystal Biotech on form 13F for the quarter ended Jun 30 '26. 25 of them hold 80% of it; FMR is largest at 14.37%.
Largest filed tie
—
Expected move
Inputs8Q avg ±6.7%·×0.77·cheap
straddle ±8.7%
spot 332.29exp Nov 20ATM strike 330ATM straddle 34.05IV 54%